Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 March 2025 | Story Andre Damons and Adele Louw | Photo Tania Allen
Agriculture Risk Financing research chair
Prof Johan van Niekerk, Vice-Dean for Agriculture for the Faculty of Natural and Agricultural Sciences; Prof Liezel Massyn, UFS Business School; Prof Nicolene Barkhuizen, Director of the UFS Business School; and Prof Cobus Oberholster, from the Agriculture Risk Financing research chair.

A newly established multi-stakeholder research chair at the University of the Free State (UFS) Business School will focus on holistic and interdisciplinary research that will create new knowledge, contribute to climate change adaptation and mitigation in the food and agricultural sector.

The Agriculture Risk Financing research chair, led by Prof Cobus Oberholster from the Business School, will also support sector specific policy development and implementation, and steer the societal discourse on climate financing and sustainable agriculture. The chair forms part of the UFS, Agricultural Research Council (ARC), and the Department of Agriculture, Land Reform and Rural Development (DALRRD) research chairs. Prof Oberholster joined the university on 1 February 2025 in this prestigious position which is a collaboration between the Business School and the UFS Department of Agricultural Economics.

Prof Oberholster, who spent a big portion of his corporate career in the banking environment, brings extensive expertise in climate finance, resource mobilisation, and sustainable economic practices. His appointment marks a significant milestone in advancing research at the intersection of finance, sustainability, and agriculture, ensuring that innovative financial solutions contribute to environmental resilience and responsible resource management. Prof Oberholster also gained extensive management experience over the past 15 years regarding the agribusiness environment (non-Bank) in South Africa with a specific focus on value-chain financing.

Focus of research chair

Says Prof Oberholster: “The research chair will strategically focus on the mainstreaming of climate-smart financing solutions within the food and agricultural sector. To achieve this, the research will focus on three strategic and interrelated pillars (Regulatory and policy, Entrepreneurial market exchanges and Digital financial innovations), which aim to provide a governance framework within which innovative financing and market mechanisms can be developed and commercialised.

“The chair will reside at the UFS Business School, but form part of a group of research chairs being hosted within the Faculty of Natural and Agricultural Science. These chairs cover the full food and agricultural value chain, which allow for leveraging the output of the chair within very specific components of the value agrifood value chain.”

The ARC-DALLRD-UFS research chairs were established last year in an effort to address the challenges and impact of climate change in Southern Africa and fall under the umbrella of climate change.

Prof Oberholster, who completed two doctoral degrees focusing on agriculture, agricultural development, and agricultural financing, says he is excited to be part of this joint initiative, and the opportunity to share his business and financing experience. “Climate change, and the corresponding need to find innovative financing solutions, is currently one of the biggest global challenges. It requires an accelerated and responsible approach to research and innovation which, together with the university’s trusted reputation, must be used to build social licence for disruptive technological solutions.”

Contributing to food security

According to Prof Oberholster, both the UFS Business School and the faculty, are ideally suited to find complementary commercial solutions for accessing and mobilising climate finance in South Africa and the wider African continent. The chair, through the UFS Business School, will also focus on capacity building which will be done through selected training and educational interventions, with the aim of addressing existing constraints in mobilising and accessing climate finance.

“The chair will focus on the integration of social, ethical and environmental parameters into climate-financing decisions. By focusing on these key sustainability aspects, access to climate finance will not only contribute to specific development objectives but also significantly contribute to food security,” Prof Oberholster says.

“Climate change, and the corresponding need to find innovative financing solutions, is currently one of the biggest global challenges. As such I’m looking forward to guide the creation of new knowledge in this specialised field, and especially to find complementary commercial solutions for accessing and mobilising climate finance in South Africa and the bigger African continent. What is standing out for me is the level of expertise available within the UFS, and the willingness of academics to work together on grand challenges such as climate finance. This is a winning recipe.”

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept